From my perspective the cellular pathway section is the most interesting. Yes we knew that bis and dec worked well together in AML, but how was not known. Mechanism of action understanding is very important for clinical development these days.
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene shows potent anticancer activity in AML models
Ann: Bisantrene shows potent anticancer activity in AML models, page-25
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M |
Open | High | Low | Value | Volume |
$1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 8662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11695 | 1.710 |
1 | 500 | 1.700 |
1 | 500 | 1.690 |
1 | 5934 | 1.685 |
1 | 5970 | 1.675 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 570 | 1 |
1.730 | 943 | 1 |
1.845 | 2500 | 1 |
1.895 | 16000 | 1 |
1.900 | 8662 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |